Stoke Therapeutics (STOK) Equity Ratio: 2022-2025
Historic Equity Ratio for Stoke Therapeutics (STOK) over the last 4 years, with Sep 2025 value amounting to 0.86.
- Stoke Therapeutics' Equity Ratio rose 8.07% to 0.86 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.86, marking a year-over-year increase of 8.07%. This contributed to the annual value of 0.84 for FY2024, which is 20.69% up from last year.
- Stoke Therapeutics' Equity Ratio amounted to 0.86 in Q3 2025, which was down 1.82% from 0.87 recorded in Q2 2025.
- Stoke Therapeutics' Equity Ratio's 5-year high stood at 0.87 during Q2 2025, with a 5-year trough of 0.68 in Q1 2024.
- Its 3-year average for Equity Ratio is 0.78, with a median of 0.79 in 2024.
- In the last 5 years, Stoke Therapeutics' Equity Ratio dropped by 9.86% in 2024 and then rose by 25.79% in 2025.
- Over the past 4 years, Stoke Therapeutics' Equity Ratio (Quarterly) stood at 0.72 in 2022, then fell by 3.20% to 0.70 in 2023, then increased by 20.69% to 0.84 in 2024, then grew by 8.07% to 0.86 in 2025.
- Its Equity Ratio was 0.86 in Q3 2025, compared to 0.87 in Q2 2025 and 0.86 in Q1 2025.